Inherited or Acquired Lipodystrophy Information and Resources
Fund Status and Eligibility
Fully Allocated - Effective 06/05/2018, we are unable to process applications that are pending or accept new or renewal applications at this time. Should additional funding for Inherited or Acquired Lipodystrophy Fund applicants become available in the future, it will be necessary to re-apply if assistance is still needed.
Maximum Award Level: $7,500 Per Year
- Patient must be insured and insurance must cover the medication for which patient seeks assistance.
- Patient must have a confirmed diagnosis of Inherited or Acquired Lipodystrophy.
- Patient must reside and receive treatment in the United States.
- Patient's income must fall below 400% of the Federal Poverty Guideline (FPG) with consideration of the Cost of Living Index (COLI) and the number in the household.
Get Help With Your Treatment: How to Apply Online
Information About the DiseaseLipodystrophies are disorders of adipose tissue (fat) characterized by selective loss of fat from various parts of the body. There are several different types of lipodystrophies and the degree of fat loss may vary from very small depressed areas to near complete absence of adipose tissue.
The extent of fat loss may determine the severity of metabolic complications related to insulin resistance, such as diabetes mellitus and high levels of serum triglycerides. Some patients may have only cosmetic problems while others may also have severe metabolic complications. These disorders can either be inherited (familial or genetic) lipodystrophies or can be secondary to various types of illnesses or drugs (acquired lipodystrophies).
The following is a listing of the types of Lipodystrophy:
Inherited• Inherited: Congenital Generalized (CGL; Berardinelli-Seip Syndrome)
• Inherited: Familial Partial, Dunnigan Variety (FPLD)
• Inherited: Familial Partial, Mandibuloacral Dysplasia Variety (FPL-MAD)
• Inherited: Familial Partial, Kobberling Variety and Other Types
• Inherited: SHORT Syndrome
• Inherited: Neonatal Progeroid Syndrome (Wiedemann-Rautenstrauch syndrome)
• Progeria (Hutchison - Gilford syndrome)
• Atypical Progeria Syndrome
Acquired• Acquired: Generalized Lipodystrophy (AGL; Lawrence Syndrome)
• Acquired: Lipodystrophy in HIV infected Patients (LD-HIV)
• Acquired: Partial Lipodystrophy (Barraquer-Simons Syndrome)
• Acquired: Localized
The University of Texas Southwestern Medical Center
National Organization for Rare Disorders
Phone: 800-999-6673 - http://nordphysicianguides.org/lipodystrophies/
Phone: 209-845-7273 - http://www.lipodystrophyunited.org/
Lipodystrophy United Resources
Phone: 209-845-7273 - http://www.lipodystrophyunited.org/research.html
National Institute for Advancing Translational Sciences/ Office of Rare Diseases Research /Genetic and Rare Diseases Information Center (GARD)
Phone: 301-402-4336 - http://rarediseases.info.nih.gov/gard/6909/lipodystrophy/resources/1
National Institute of Health-Clinical Trial Center
Phone: 301-496-4121 - http://cc.nih.gov/translational-research-resources/diseases/lipodystrophy.html
The Patient Advocate Foundation's (PAF) Co-Pay Relief (CPR) Program does not review the information contained on the website links provided for content, accuracy or completeness. Use of and access to this information is subject to the terms, limitations and conditions as outlined on the accessed websites.
PAF Co-Pay Relief Program makes no representation as to the accuracy or any other aspect of the information contained on any website accessed from the CPR website, nor does PAF Co-Pay Relief Program necessarily endorse the website information provided.
The information presented on the PAF Co-Pay Relief website is provided for general information only and is not intended as a substitute for medical care. Please talk with your healthcare provider about any information you acquire from this or any other website accessed through the PAF Co-Pay Relief program website.